BioMarin Pharmaceutical Inc

NAS:BMRNHealthcareNASDAQ:NBISTOXX:EDD24BP

$54.67−0.02%At closeAt close · Tue 20 Oct · ≈ AED 200.78 · Market cap $10.58B · Next earnings Mon 26 Oct · Extended $55.12 +0.82%

USD billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Cash & cash equivalents	0.6	0.6	0.7	0.8	0.9	1.3	+39.1%
Cash & short-term investments	1.1	1.0	1.3	1.1	1.1	1.6	+37.2%
Receivables	0.4	0.4	0.5	0.6	0.7	0.9	+37.5%
Inventory	0.7	0.8	0.9	1.1	1.2	1.3	+5.4%
Total current assets	2.3	2.3	2.8	3.0	3.2	4.0	+22.3%
Property, plant & equipment	1.0	1.0	1.1	1.1	1.0	1.0	−8.7%
Goodwill & intangibles	0.6	0.6	0.5	0.5	0.5	0.4	−9.2%
Long-term investments	0.3	0.5	0.3	0.6	0.5	0.5	−4.4%
Total assets	5.8	6.0	6.4	6.8	7.0	7.6	+8.7%
Payables	0.2	0.2	0.2	0.3	0.2	0.3	+32.9%
Short-term debt	0.0	0.0	0.0	0.5	0.0	0.0	−62.4%
Total current liabilities	0.5	0.5	0.6	1.2	0.6	0.8	+25.0%
Long-term debt	1.1	1.1	1.1	0.6	0.6	0.6	+0.3%
Total debt	1.1	1.1	1.1	1.1	0.6	0.6	−1.0%
Net debt	0.4	0.5	0.4	0.3	(0.3)	(0.7)	−128.0%
Deferred revenue	0.0	0.0	0.0	0.0	0.0	0.0	−100.0%
Total liabilities	1.7	1.7	1.8	1.9	1.3	1.5	+13.2%
Total equity	4.1	4.3	4.6	5.0	5.7	6.1	+7.6%
Retained earnings	(0.9)	(0.9)	(0.8)	(0.6)	(0.2)	0.2	+179.2%